200 results about "Immune complex deposition" patented technology

The invention provides an immunodetection method of a multi-index immune checkpoint detection kit, which belongs to the technical field of immunodetection and comprises three main stages of sample preparation, immune reaction and data analysis. The method comprises the following steps: firstly, carrying out centrifugal separation to obtain a plasma sample, and preparing a fluorescent microsphere coupled capture antibody and biotin labeled detection antibody compound; then carrying out immune reaction, forming a sandwich type immune complex through specific binding, and adding streptavidin marked by phycoerythrin for signal amplification. Detecting a fluorescence signal by adopting a flow cytometer to obtain an original data matrix; a contribution feature vector, a utility feature vector and an expression feature matrix are extracted through a feature decomposition algorithm, and a deep learning model of a total-score-total structure is established for data analysis. Finally, a detection report containing a quantitative result, an importance score and reliability evaluation is generated, and the technical problem that in the prior art, the analysis accuracy of a multi-index immune checkpoint detection result is insufficient is solved.

The invention relates to the technical field of bacterium detection, in particular to a colorimetric-Raman coding immunochromatography test strip based on a 3D film-shaped SERS probe and a multi-bacterium detection method thereof. According to the technical scheme, the kit comprises a sample pad, a nitrocellulose membrane, a water absorption pad, a 3D membrane-like SERS probe and an operation buffer solution. According to the present invention, the immunochromatography of the 3D film-like probe is provided, the MoDAu-coated Ag SERS nano-film is adopted as the probe in the system, such that the pathogenic bacteria can be highly specifically recognized and captured, the immune complex fluidity can be increased, the rapid quantitative detection of the three pathogenic bacteria can be achieved, and the flexible 3D film-like SERS probe capable of enhancing the colorimetric ability and the SERS activity and highly specifically capturing the pathogenic bacteria can be prepared; by combining with an antibody-modified ICA test strip, rapid, simultaneous and quantitative determination of various pathogenic bacteria is realized.

The invention relates to the technical field of mass spectrometric detection and analysis, and particularly discloses an organic mass spectrometric analysis method for detecting tumor biomarkers, which comprises the following steps: S1, synthesizing gold nanoparticles; s2, sequentially assembling a CEA detection antibody modified by a connecting arm and a mass spectrum tag molecule on the surface of a gold nanoparticle through an Au-S bond to obtain a mass spectrum probe; s3, preparing the modified magnetic beads; s4, taking the modified magnetic beads as capture units, and adding a to-be-detected sample and a mass spectrum probe for immunoreaction; then the gold nanoparticles are released from the immune complex, and supernate is collected; and S5, detecting the supernate in a high-resolution mass spectrum to obtain the concentration of the antigen in the sample to be detected. When the mass spectrum tag molecule is used for organic mass spectrum analysis and tumor biomarkers are detected, a plurality of antibodies can be marked at the same time, so that simultaneous detection of multiple targets is realized; and the method has good sensitivity and detection stability.

Systemic lupus erythematosus (SLE) is an autoimmune disease in which circulating immune complexes can cause different types of glomerulonephritis, according to immune deposits and to the type of glomerular cell injury. Proliferative lesions represent the most severe form of lupus nephritis (LN) and often lead to kidney failure and death. Mucosal-associated invariant T (MAIT) are a subset of innate-like T cells that recognize microbial-derived ligands from the riboflavin synthesis pathway. Now the inventors analyzed the phenotype and function of peripheral blood MAIT cells by flow cytometry in 26 patients with LN and in a control group of 16 healthy volunteers. The inventors found that MAIT cell frequencies are markedly reduced in blood of LN patients. More particularly, among LN patients, baseline MAIT cell frequency, Ki-67 expression evaluating proliferative activity and granzyme B production measuring cytotoxicity represent promising prognostic factors of renal response one year after induction therapy. In conclusion, the inventors showed that baseline frequency and cytotoxic profile of MAIT cells may represent a promising prognostic factor of renal remission one year after induction therapy.

Provided is a method of testing an analyte in a sample. The method comprises: causing a first proximity probe and a second proximity probe to bind to an analyte in a sample in sequence to form an immune complex, the immune complex being captured on a solid-state matrix by means of binding of the first proximity probe to a capture probe, and adding a blocker after the first proximity probe binds to the capture probe and before the second proximity probe is added, the blocker binding to the capture probe to reduce non-specific binding of the capture probe to molecules other than the immune complex. Also provided is a blocker for the method.

The invention discloses a digital analysis method and system based on nano lens high signal-to-noise ratio holographic imaging, and belongs to the field of biochemical analysis. According to the invention, the microsphere nanoprobe is combined with a high signal-to-noise ratio holographic microscopic imaging technology, the number of microsphere signal probes in a supernatant / immune complex is changed through a series of biochemical reactions, and high signal-to-noise ratio holographic imaging is carried out on the PS microsphere nanoprobe in the supernatant after magnetic separation; in the holographic imaging process, the surface acoustic wave-interdigital transducer is used for driving and forming a high-signal-to-noise-ratio lensless holographic microscope of a nano lens; and obtaining the number of the microsphere signal probes in the holographic image by using a lightweight unsupervised learning target detection algorithm, and finally realizing accurate quantitative detection of the target object to be detected. Experimental results show that the detection sensitivity and efficiency are effectively improved, and meanwhile the detection accuracy is improved.

The invention discloses a confinement composite nano-enzyme enhanced electrochemiluminescence immunosensor for detecting tumor necrosis factors and a construction method and application of the immunosensor. The immunosensor is a three-electrode system, and liquid to be detected contains luminol; wherein the working electrode is obtained by covalently immobilizing a tumor necrosis factor specific antibody after an SNF epoxy modified electrode is subjected to confinement of Ni (OH) 2-CeO2 composite nano-enzyme and then closing a non-specific site. The Ni (OH) 2-CeO2 composite nano-enzyme is confined in a nano-channel, the Ni (OH) 2-CeO2 composite nano-enzyme and the nano-channel can synergistically accelerate the process of an oxygen reduction reaction, the modification stability of the nano-enzyme is effectively improved, and a formed immune complex causes increase of interface resistance and steric hindrance of a sensing electrode to cause signal reduction; therefore, high-sensitivity detection of the tumor necrosis factor is realized, and the constructed sensor has the advantages of low detection limit, wide detection range and the like, and is very suitable for being widely applied to the fields of auxiliary clinical diagnosis, large-scale screening, health monitoring and the like.

A reagent combination, a kit, a detection system and a detection method for detecting a small molecule substance. In the condition that a solution to be tested does not contain or contains a small amount of the small molecule substance, an antibody binds to a substrate protein conjugate to form an immune complex, a stem-loop structure is generated by means of a complementary pairing among a plurality of nucleic acid molecules, a first fluorescent group excites a second fluorescent group to emit a second fluorescence on the basis of fluorescence resonance energy transfer, and the content of the small molecule substance is calculated. In the condition that the solution to be tested contains a large amount of the small molecule substance, the immune complex and the stem-loop structure cannot be formed, and the second fluorescent group cannot emit the second fluorescent.

The invention discloses a chimeric antigen receptor modified cell drug as well as a preparation method and application thereof, and belongs to the technical field of cell drugs. A cell drug is obtained by introducing a chimeric antigen receptor targeting B cells and / or plasma cells into in-vitro or in-vivo immune cells through a gene delivery system, and target spots of the targeted B cells and / or plasma cells comprise CD19, BCMA, CD20, CD22, CD38, CD138, GPRC5D and SLAMF7. The chimeric antigen receptor modified cell drug can realize specific recognition of B cells and / or plasma cells and activate immune cells through a specific single-chain antibody fragment (scFv), and can specifically remove the B cells in vitro and in vivo, thereby preventing the generation of autoimmune antibodies and the formation of immune complexes, achieving the purpose of thoroughly treating diseases, and having good application prospects. The life quality of a patient is improved, the disease is finally cured, and the application potential and the commercial value are huge.

The invention discloses a biochemical immunodetection device and a biochemical immunodetection method for ursodesoxycholic acid reduzate, and belongs to the technical field of ursodesoxycholic acid reduzate detection. The ursodesoxycholic acid reduzate detection device comprises a detection box and a lifter at the bottom of the detection box, a dissolution preparation part and a centrifugal part are arranged in the detection box, and the dissolution preparation part can fully dissolve an ursodesoxycholic acid reduzate-containing medicament; the centrifugal part is used for carrying out precipitation separation on the dissolved medicament; the detector can accurately collect fluorescence signals of the immune complex; according to the ursodesoxycholic acid reduzate detection device, the integrated operation of detection test tube fixing, cover opening and transferring, medicament adding, cover closing and plug sealing and dissolving is achieved, the steps of automatic medicament filling, sealing and the like are achieved, the medicament preparation efficiency is greatly improved, efficient and accurate detection of ursodesoxycholic acid reduzate is further achieved, and the detection efficiency is improved. And complex and tedious manual operation is avoided, and the situation that the sample is easily polluted by manual operation is avoided.

The present invention discloses a cleaning device and a chemiluminescent immunoassay analyzer having the same, wherein the cleaning device comprises a frame and a conveying mechanism, a cleaning needle mechanism, and a magnet mechanism arranged on the frame, wherein the frame is provided with a liquid aspiration station and a liquid injection station; the conveying mechanism comprises a turntable and a first driving assembly capable of driving the turntable, wherein the turntable is provided with a cup placement hole for placing a reaction cup, the conveying mechanism can transport the reaction cup to different stations, and the turntable can reciprocate; the cleaning needle mechanism corresponds to the liquid aspiration station and the liquid injection station and can absorb waste liquid from the reaction cup and inject cleaning liquid into the reaction cup; the magnet mechanism comprises at least one active magnet assembly arranged corresponding to the liquid aspiration station, and the active magnet assembly can adsorb the immune complex in the reaction cup to the cup wall and can drive it to move upward. The present invention has a good washing and separation effect on the immune complex and a high working efficiency.

The invention provides a method for rapidly detecting fluorescently-labeled allergens for hygienic products, and relates to the technical field of detection of hygienic products. The rapid fluorescently-labeled allergen detection method for the hygienic products comprises the following steps: combining a fluorescently-labeled substance with an allergen specific antibody through a chemical coupling method to form a stable fluorescently-labeled antibody compound; fixing the fluorescence labeled antibody on the surface of a reaction chamber of a micro-fluidic chip; introducing a hygienic product sample or an extract thereof into the chip, and combining the hygienic product sample or the extract thereof with the fixed fluorescently-labeled antibody to form an'allergen-antibody-fluorescently-labeled 'immune complex; a detection area is irradiated by an excitation light source, fluorescence intensity is monitored in real time by a photoelectric sensor, and a detection result is generated by combining a data analysis module. According to the invention, the rapid and high-sensitivity detection of allergens in hygienic products is realized by combining a fluorescence labeled antibody with a microfluidic technology.

The present disclosure concerns a microfluidic method of assaying antibody secreting cells (ASCs), comprising the steps of isolating ASCs within droplets such that each droplet encapsulates only one ASC; incubating the droplets of step a) to accumulate antibodies within the droplets; picoinjecting virus into the droplets of step b) to form immune complex droplets; picoinjecting host cells into the immune complex droplets to form neutralised droplets and infected droplets; and sorting the infected droplets from the neutralised droplets, b based on infection of the host cells by the virus, to assay the ASCs within the neutralised droplets. The present disclosure also concerns a microfluidic platform thereof.

The invention belongs to the technical field of biological medicine, and particularly relates to an anti-human DCBLD2 nano antibody and application thereof. The anti-DCBLD2 nano antibody is successfully screened by using a phage display technology, and the nano antibody can be specifically combined with human DCBLD2 protein, can be prepared into an immune complex or a pharmaceutical composition for preventing or treating DCBLD2 target related diseases, and has a wide application prospect.

The invention provides an aldosterone antigen binding molecule and application thereof, and relates to the technical field of biology. The aldosterone antigen binding molecule is selected from a first antigen binding molecule containing CDR sequences as shown in SEQ ID NO.1 and SEQ ID NO.2 or a second antigen binding molecule containing CDR sequences as shown in SEQ ID NO.3 and SEQ ID NO.4. The aldosterone antigen binding molecule can bind an aldosterone antigen, and can be used for a method or a product for detecting aldosterone based on an immunological principle; the first antigen binding molecule and the second antigen binding molecule can also form an immune complex with a double-antibody sandwich structure with aldosterone, so that aldosterone is detected by a double-antibody sandwich principle.

Disclosed herein is a method for treating immune complex-mediated membranoproliferative glomerulonephritis (IC-MPGN) with the factor B inhibitor iptacopan or a pharmaceutically acceptable salt thereof (e.g., iptacopan hydrochloride).

This invention discloses a quantitative test strip for HBV PreS1 antibody based on the AIE molecule, its preparation method, and its applications, relating to the fields of molecular biology, immunology, and biodetection technology. The test strip includes a sample pad, a labeling pad, a nitrocellulose membrane (NC membrane), an absorbent pad, and a base plate. The NC membrane detection line is coated with HBV PreS1 antigen to capture PreS1 antibodies in the sample. The labeling pad contains an immobilized Anti-Human IgG antibody conjugated to the AIE molecule, which binds to the PreS1 antibodies in the sample to form an immune complex. The test strip of this invention enables rapid detection of PreS1 antibodies and achieves enhanced fluorescence in the detection results. Combined with a fluorescence reader or fluorescence card reader, the detection results can be digitally and quantitatively analyzed. It is simple to operate, rapid in detection, and significantly improves detection sensitivity and enables quantitative analysis.

The invention relates to a preparation method of a CpG ODN nano immune complex, which comprises the following steps: (1) uniformly mixing a protamine solution with a certain concentration and a CpG motif-containing oligodeoxynucleotide CpG ODN aqueous solution with a certain concentration according to a certain ratio, and carrying out electrostatic compounding assembly at room temperature to form a suspension; and (2) applying energy to the suspension to disperse / homogenize uniformly to form the suspension of the nano-composite. The nano-composite prepared by the method disclosed by the invention is controllable in particle size and controllable in surface charge. The nano particles formed under the preparation condition of an optimized proportion are uniformly dispersed, good in stability, good in resolubility after freezing, and good in long-term storage stability. The preparation method provided by the invention is simple, does not involve toxic and harmful chemical substances, and is suitable for amplification. Compared with the prior art, the preparation method provided by the invention can obviously improve the effective concentration of the effective active substance CpG ODN in the nano immune complex. The invention also relates to the nano immune complex prepared by the method and application thereof. Cell and animal experiments prove that the nano immune complex prepared by the method has good immunostimulatory activity, can stimulate the maturation of related immune cells and induce the secretion of related cytokines, can be independently used as an immunomodulator, and can also be used as an immunologic adjuvant to be combined with various antigens to be used as a vaccine preparation as a whole. The nano immune complex has good application prospects in the fields of inducing and activating immune cells to mature, releasing cytokines, resisting allergic diseases, preventing and treating microbial infectious diseases, vaccine adjuvants, resisting tumor immunotherapy and resisting Alzheimer's disease.

In certain embodiments, the present invention provides a method for detecting an anti-drug antibody (ADA) in a sample, comprising: a) pre-treating the sample at a high temperature to dissociate the ADA: drug immune complex in the sample; b) isolating the ADA from the sample by a matrix; c) retrieving the ADA from the matrix using a buffer, and d) detecting the ADA in a cell-based assay or an in vitro assay.

The invention belongs to the technical field of genetic engineering antibodies, and particularly relates to an antibody for non-competitive detection of aflatoxin B1 and application of the antibody. The antibody comprises a nano antibody of an anti-aflatoxin B1 antigen-antibody immune complex and a monoclonal antibody of the anti-aflatoxin B1; the amino acid sequence of the nano antibody of the anti-aflatoxin B1 antigen-antibody immune complex is as shown in SEQ ID NO. 1; the monoclonal antibody for resisting aflatoxin B1 comprises a heavy chain and a light chain; the amino acid of the heavy chain is as shown in SEQ ID NO.10, and the amino acid of the light chain is as shown in SEQ ID NO.11. The antibody for non-competitive detection of aflatoxin B1 provided by the invention is low in cost, can be prepared on a large scale through a prokaryotic expression system, is simple and convenient to prepare, has strong operability, and can be applied to non-competitive immunological analysis of aflatoxin B1.

Described herein are methods of treating immune complex mediated membrane proliferative glomerulonephritis (IC-MPGN) with a factor B inhibitor ipropam or a pharmaceutically acceptable salt thereof, e.g., ipropam hydrochloride.

Novel binding molecules comprising humanized antibodies, fragments, variants, and derivatives thereof, as well as compositions, methods, and kits comprising the same, are described, wherein the binding molecules specifically bind to FX1 and FX1a. The binding molecules are capable of binding to the factor X1A2 domain and forming immune complexes, thereby disrupting the contact activation molecule complex without affecting the activity or activation of hemostatic factor XI. The binding molecules disclosed herein are suitable for safely inhibiting thrombosis and inflammation without impairing hemostasis. Thus, the binding molecules, compositions, methods, and kits provided herein are intended for treating diseases and conditions, particularly those associated with thrombosis and inflammation. In addition, polynucleotides encoding the binding molecules disclosed herein, vectors comprising the polynucleotides, and host cells for producing the polynucleotides are also provided.

An immunoassay method and system, the method comprising: a detection step, comprising providing a test solution containing a carrier immune complex, the carrier immune complex comprising a solid phase carrier, a luminescent material and a test object, under the action of a sheath flow, the test solution flows through a detection zone, and a scattering signal M of the solid phase carrier and a luminescent signal N of the luminescent material in the detection zone are collected; a calculation step, comprising calculating the concentration of the test object in the test solution according to the scattering signal M collected from the solid phase carrier and the luminescent signal N collected from the luminescent material. The present invention realizes digital segmentation from a physical principle through hydraulic focusing, does not require microplate consumables, and at the same time uses less solid phase carriers, is convenient and easy to obtain, and can achieve a dynamic detection range of 5 orders of magnitude.

The present invention relates to a biochemical assay method, which uses a hapten-fixed test probe and reagents repeatedly to quantify analytes in different samples or measure kinetic binding in different samples while maintaining acceptable assay performance, for any number of about 3 to 20 times. The method uses a conjugate solution comprising (i) an anti-hapten antibody and a capture antibody against the analyte or (ii) an anti-hapten antibody and streptavidin in each cycle, and after each reaction cycle, the hapten-coated test probe is regenerated by immersing the test probe in an acidic solution with a pH of about 1 to 4 and optionally further immersing it in a DMSO solution. The robustness of the hapten-fixed solid phase allows the use of denaturing reagents to efficiently elute immune complexes after each cycle without reducing the binding activity of the hapten on the solid phase.

The application relates to a preparation method and application of a sandwich type photoelectrochemical immunosensor based on a Bi2S3 / BiOCl composite material, and belongs to the field of novel functional materials and biosensing detection technology; the Bi2S3 / BiOCl composite material is used as a base material, and visible light is used as a light source to obtain a photoelectric current; the two components of the base material are well matched in bands, greatly improving photoelectric conversion efficiency, so that a large output signal is obtained; different concentrations of the NSE solution to be measured result in different amounts of immune complexes, further resulting in different degrees of influence on photoelectric signals; the sensor shows high sensitivity, a wide detection range and a low detection limit to target objects, can realize rapid and sensitive determination of NSE in human serum, and has great application value for judging diseases of patients in the clinic.

The present invention relates to a method and / or kit for diagnosing whether an individual suffers from peripheral neuropathy pain. The method comprises detecting advillin in a biological sample by detecting an immune complex formed by advillin and a monoclonal antibody that specifically binds thereto. The present invention also encompasses a method for treating an individual suffering from peripheral neuropathy pain.

An artificial immune complex (IC) free in solution, the artificial IC comprising a nucleic acid (NA) folding comprising stapled NA strands, the NA folding having an outer surface patterned with addressable sites and epitopes bound to the addressable sites and displayed in three dimensions for recruiting antibodies free in solution.

This disclosure relates to RNAi agents capable of inhibiting complement factor B (CFB) gene expression. Pharmaceutical compositions containing CFB RNAi agents and methods of use thereof are also disclosed. The CFB RNAi agents disclosed herein may be conjugated to a targeted ligand containing an N-acetyl-galactosamine ligand to facilitate in vivo delivery to hepatocytes. RNAi agents can be used in methods of treating diseases, disorders, or conditions partially mediated by CFB gene expression, including IgA nephropathy (IgAN), C3 glomerulopathy (C3G), immune complex-mediated membrane proliferative glomerulonephritis (IC-MPGN), lupus nephritis (LN), anti-glomerular basement membrane antibody disease (anti-GBM), ischemia-reperfusion injury and T-cell-mediated rejection in kidney transplantation (TCMR), anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, age-related macular degeneration (AMD) including early and / or intermediate-stage AMD, geographic atrophy (GA), glaucoma, Doyne honeycomb retinal dystrophy, paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), pre-eclampsia, rheumatoid arthritis (RA), and / or other complement-mediated disorders.

The invention discloses a preparation method and application of a clothianidin fluorescent test strip, belongs to the technical field of agricultural detection, and solves the problems that the existing bombyx mori pesticide poisoning detection sensitivity is low, and the clothianidin residue concentration cannot be quickly judged. According to the method, a nitrocellulose membrane is prepared, a detection line is coated with a clothianidin-BSA antigen, and a quality control line is coated with an anti-mouse IgG antibody; when the fluorescent pad is prepared, carboxylated fluorescent microspheres and an anti-clothianidin antibody are coupled to form a labeled probe; when the test strip is assembled, the nitrocellulose membrane, the fluorescent pad, the sample pad and the absorbent paper are stacked and fixed on the bottom plate to form a chromatography structure. Clothianidin in a sample is combined with the labeled probe to form an immune complex, chromatography migrates to the detection line to be competitively combined with clothianidin-BSA antigen, the uncombined probe is captured and develops color, and the quality control line develops color through an anti-mouse IgG antibody. The test strip is used for rapidly detecting clothianidin residues in mulberry leaves and bombyx mori bodies, the sensitivity reaches 0.02 mg / L, pesticide poisoning events can be effectively prevented, and safe production of the sericulture industry is guaranteed.

The present invention relates to the quantification, separation and characterization of exosomes. Exosome immune complexes are constructed on beads to produce constructed immune complex beads, and target exosomes are digitally quantified by droplet microfluidics technology and exosomes are measured at the level of single exosomes by diluting and encapsulating the exosomes into a sufficient number of droplets. Quantified exosomes can be used to diagnose cancer in a subject.